Bacteriophage inspired antibiotics discovery against infection involved biofilm

Critical Reviews in Eukaryotic Gene Expression

Volumn 23, Issue 4, 2013, Pages 317-326

  Fan, Xiangyu ^a   Li, Wu ^a   Zheng, Fei ^a   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

Bacterial biofilm; Drug design; Extracellular DNA; Phage; Phage therapy; Polysaccharide depolymerases

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL POLYSACCHARIDE; BACTERIOCIN; ENDOLYSIN; ENZYME; HOMOSERINE; LACTONE; LONG CHAIN FATTY ACID; LYSIN; LYSOZYME; NUCLEIC ACID; POLYSACCHARIDE DEPOLYMERASE; POLYSACCHARIDE LYASE; QUINOLONE; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIOPHAGE; BIOFILM; ESCHERICHIA COLI; GENDER; GROWTH INHIBITION; HOST; HOST PATHOGEN INTERACTION; HUMAN; LYSIS; NONHUMAN; PRIORITY JOURNAL; PROPHAGE; PSEUDOMONAS AERUGINOSA; SHEWANELLA ONEIDENSIS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BACTERIOPHAGES; BIOFILMS; DRUG DISCOVERY; VIRAL PROTEINS;

EID: 84887115076     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukaryotGeneExpr.2013007717     Document Type: Article

References (64)

1. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science. 2002 Feb 22; 295(5559): 1487.
2. Matsukawa M, Greenberg EP. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J Bacteriol. 2004 Jul; 186(14): 4449-56.
3. Steinberger RE, Holden PA. Extracellular DNA in singleand multiple-species unsaturated biofilms. Appl Environ Microbiol. 2005 Sep; 71(9): 5404-10.
4. Izano EA, Amarante MA, Kher WB, Kaplan JB. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol. 2008 Jan; 74(2): 470-6.
5. Thomas VC, Hiromasa Y, Harms N, Thurlow L, Tomich J, Hancock LE. A fratricidal mechanism is responsible for eDNA release and contributes to biofilm development of Enterococcus faecalis. Mol Microbiol. 2009 May; 72(4): 1022-36.
6. Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, Molin S, Qu D. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology. 2007 Jul; 153(Pt 7): 2083-92.
7. Godeke J, Paul K, Lassak J, Thormann KM. Phage-induced lysis enhances biofilm formation in Shewanella oneidensis MR-1. ISME J. 2011 Apr; 5(4): 613-26.
8. May T, Tsuruta K, Okabe S. Exposure of conjugative plasmid carrying Escherichia coli biofilms to male-specific bacteriophages. ISME J. 2011 Apr; 5(4): 771-5.
9. Reisner A, Holler BM, Molin S, Zechner EL. Synergistic effects in mixed Escherichia coli biofilms: conjugative plasmid transfer drives biofilm expansion. J Bacteriol. 2006 May; 188(10): 3582-8.
10. Reisner A, Krogfelt KA, Klein BM, Zechner EL, Molin S. In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors. J Bacteriol. 2006 May; 188(10): 3572-81.
11. Spoering AL, Gilmore MS. Quorum sensing and DNA release in bacterial biofilms. Curr Opin Microbiol. 2006 Apr; 9(2): 133-7.
12. Danhorn T, Fuqua C. Biofilm formation by plant-associated bacteria. Annu Rev Microbiol. 2007; 61: 401-22.
13. Richards JJ, Melander C. Controlling bacterial biofilms. Chembiochem. 2009 Sep 21; 10(14): 2287-94.
14. Ojha A, Anand M, Bhatt A, Kremer L, Jacobs Jr WR, Hatfull GF. GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell. 2005; 123(5): 861-73.
15. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002 Apr; 15(2): 167-93.
16. Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother. 2005 Aug; 56(2): 331-6.
17. Burmolle M, Webb JS, Rao D, Hansen LH, Sorensen SJ, Kjelleberg S. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol. 2006 Jun; 72(6): 3916-23.
18. Petrova OE, Schurr JR, Schurr MJ, Sauer K. The novel Pseudomonas aeruginosa two-component regulator BfmR controls bacteriophage-mediated lysis and DNA release during biofilm development through PhdA. Mol Microbiol. 2011; 81(3)767-83.
19. Rice SA, Tan CH, Mikkelsen PJ, Kung V, Woo J, Tay M, Hauser A, McDougald D, Webb JS, Kjelleberg S. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME J. 2009 Mar; 3(3): 271-82.
20. Wang X, Kim Y, Ma Q, Hong SH, Pokusaeva K, Sturino JM, Wood TK. Cryptic prophages help bacteria cope with adverse environments. Nat Commun. 2010; 1: 147.
21. Doolittle MM, Cooney JJ, Caldwell DE. Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J Ind Microbiol. 1996 Jun; 16(6): 331-41.
22. Sillankorva S, Neubauer P, Azeredo J. Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A. BMC Biotechnol. 2008; 8: 79.
23. Soni KA, Nannapaneni R. Removal of Listeria monocytogenes biofilms with bacteriophage P100. J Food Protect. 2010; 73(8): 1519-24.
24. Azeredo J, Sutherland IW. The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol. 2008; 9(4): 261-6.
25. Sutherland IW, Hughes KA, Skillman LC, Tait K. The interaction of phage and biofilms. FEMS Microbiol Lett. 2004 Mar 12; 232(1): 1-6.
26. Sutherland IW. Polysaccharide lyases. FEMS Microbiol Rev. 1995 Jul; 16(4): 323-47.
27. Sutherland IW. Polysaccharases for microbial exopolysaccharides. Carbohydr Polym. 1999; 38(4): 319-28.
28. Hughes KA, Sutherland IW, Clark J, Jones MV. Bacteriophage and associated polysaccharide depolymerases-novel tools for study of bacterial biofilms. J Appl Microbiol. 1998 Sep; 85(3): 583-90.
29. Hughes KA, Sutherland IW, Jones MV. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology. 1998 Nov; 144 (Pt 11): 3039-47.
30. Housby JN, Mann NH. Phage therapy. Drug Discov Today. 2009 Jun; 14(11-12): 536-40.
31. Curtin JJ, Donlan RM. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother. 2006 Apr; 50(4): 1268-75.
32. Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother. 2010 Jan; 54(1): 397-404.
33. Tait K, Skillman LC, Sutherland IW. The efficacy of bacteriophage as a method of biofilm eradication. Biofouling. 2002 Dec; 18(4): 305-11.
34. Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 2001 Jun; 67(6): 2746-53.
35. Glonti T, Chanishvili N, Taylor PW. Bacteriophagederived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J Appl Microbiol. 2010 Feb; 108(2): 695-702.
36. Cornelissen A, Ceyssens PJ, T'Syen J, Van Praet H, Noben JP, Shaburova OV, Krylov VN, Volckaert G, Lavigne R. The T7-related Pseudomonas putida phage phi15 displays virion-associated biofilm degradation properties. PLoS One. 2011; 6(4): e18597.
37. Lu TK, Collins JJ. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci U S A. 2007 Jul 3; 104(27): 11197-202.
38. Sass P, Bierbaum G. Lytic activity of recombinant phage {phi} 11 and {phi} 12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol. 2007; 73(1): 347-52.
39. Son JS, Lee SJ, Jun SY, Yoon SJ, Kang SH, Paik HR, Kang JO, Choi YJ. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cellwall-degrading enzyme. Appl Microbiol Biotechnol. 2010; 86(5): 1439-49.
40. Meng X, Shi Y, Ji W, Zhang J, Wang H, Lu C, Sun J, Yan Y. Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen, Streptococcus suis. Appl Environ Microbiol. 2011; 77(23): 8272-9.
41. Shen Y, Koller T, Kreikemeyer B, Nelson DC. Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. J Antimicrob Chemother. 2013 Apr 4.
42. Fenton M, Keary R, McAuliffe O, Ross RP, O'Mahony J, Coffey A. Bacteriophage-derived peptidase CHAP(K) eliminates and prevents staphylococcal biofilms. Int J Microbiol. 2013: 625341.
43. Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2010; 54(4): 1603-12.
44. Ting-yu S, Wan-yan D, Jian-ping X. Regulatory mechanism underlying pathogen biofilm formation and potential drug targets Acta Pharm Sinica. 2012; 47(2): 135-43.
45. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, Kjelleberg S, Molin S, Givskov M, Tolker-Nielsen T. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Molecular Microbiology. 2006; 59(4): 1114-28.
46. Smith RS, Iglewski BH. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J Clin Invest. 2003; 112(10): 1460-5.
47. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nature chemical biology. 2007; 3(9): 541-8.
48. Cugini C, Calfee M, Farrow III JM, Morales DK, Pesci EC, Hogan DA. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol Microbiol. 2007; 65(4): 896-906.
49. Calfee M, Coleman JP, Pesci EC. Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2001; 98(20): 11633-7.
50. Tashiro Y, Toyofuku M, Nakajima-Kambe T, Uchiyama H, Nomura N. Bicyclic compounds repress membrane vesicle production and Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa. FEMS Microbiol Lett. 2010; 304(2): 123-30.
51. Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. International journal of antimicrobial agents. 2007; 30(2): 118-28.
52. Donlan RM. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 2009 Feb; 17(2): 66-72.
53. Doolittle MM, Cooney JJ, Caldwell DE. Lytic infection of Escherichia coli biofilms by bacteriophage T4. Can J Microbiol. 1995 Jan; 41(1): 12-8.
54. Sillankorva S, Oliveira R, Vieira MJ, Sutherland IW, Azeredo J. Bacteriophage Phi S1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling. 2004 Jun; 20(3): 133-8.
55. Ahiwale S, Tamboli N, Thorat K, Kulkarni R, Ackermann H, Kapadnis B. In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage. Curr Microbiol. 2011 Feb; 62(2): 335-40.
56. Pires D, Sillankorva S, Faustino A, Azeredo J. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms. Res Microbiol. 2011 Oct; 162(8): 798-806.
57. Rahman M, Kim S, Kim SM, Seol SY, Kim J. Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling. 2011 Nov; 27(10): 1087-93.
58. Cerca N, Oliveira R, Azeredo J. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K. Lett Appl Microbiol. 2007 Sep; 45(3): 313-7.
59. Domenech M, Garcia E, Moscoso M. In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases. Antimicrob Agents Chemother. 2011 Sep; 55(9): 4144-8.
60. Siringan P, Connerton PL, Payne RJ, Connerton IF. Bacteriophage-Mediated Dispersal of Campylobacter jejuni Biofilms. Appl Environ Microbiol. 2011 May; 77(10): 3320-6.
61. Castillo-Ruiz M, Vines ED, Montt C, Fernandez J, Delgado JM, Hormazabal JC, Bittner M. Isolation of a novel Aggregatibacter actinomycetemcomitans serotype b bacteriophage capable of lysing bacteria within a biofilm. Appl Environ Microbiol. 2011 May; 77(9): 3157-9.
62. Verma V, Harjai K, Chhibber S. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling. 2010 Aug; 26(6): 729-37.
63. Verma V, Harjai K, Chhibber S. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J Antimicrob Chemother. 2009 Dec; 64(6): 1212-8.
64. Sillankorva S, Neubauer P, Azeredo J. Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus. Biofouling. 2010 Jul; 26(5): 567-75.